Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6-year retrospective study.

CONCLUSIONS: Respiratory syncytial virus in hospitalized adults is associated with significant morbidity and mortality with 26.9% requiring ICU level care. Antibiotics are commonly prescribed to patients with documented RSV, and antibiotics are frequently continued after diagnosis. Novel antiviral therapies are needed for RSV to improve outcomes and potentially improve antibiotic stewardship in patients without a bacterial infection. PMID: 30977284 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30977284?dopt=Abstract

Source: Respiratory Care - April 10, 2019 Category: Respiratory Medicine Authors: Schmidt H, Das A, Nam H, Yang A, Ison MG Tags: Influenza Other Respir Viruses Source Type: research